(marrow)
Â
Â
Â
Â
Â
Â
Â
Pneumonia in Children
Learning objectives
- Define Community Acquired Pneumonia
- Describe the clinical presentation of CAP in different age groups
- List the causative organisms of CAP in these age groups
- List the investigations that are needed for diagnosis and management community acquired pneumonia (CAP)
- Discuss the management of CAP including the choice of antibiotics
What is pneumonia?
- Pneumonia is an infection of the lungs
Pneumonia is an inflammation of the parenchyma of the lungs
- It is characterised by inflammation of the alveoli
- Alveolar space are filled with secretions
- interferes with air exchange
- Causes hypoxia
Pathogenesis
- Invasion of alveoli and terminal air spaces by microorganisms - inhaled or via the blood stream
- Inflammatory cascade triggers leakage of plasma and loss of surfactant resulting in air loss and consolidation
- Activated inflammatory cascade results in
- injury to host tissues
- alter endothelial and epithelial integrity
- alter the vascular tone and intravascular haemostasis
Community Acquired Pneumonia
- Presence of signs and symptoms of pneumonia in a previously healthy child due to an infection that has been acquired in the community
Ideally, the definition should include the isolation of a responsible organism - In CAP this is not possible in s significant proportion of cases
Why is paediatric pneumonia important?
- Paediatric pneumonia is a killer
- Pneumonia claims the life of a child every 20 seconds.
- According to UNICEF 3 million children die of pneumonia evert year
- 98 percent of pneumonia-induced deaths occur in developing countries
- These deaths are more likely in children with underlying conditions such as congenital heart disease, chronic lung disease of prematurity or immunodeficiency
Paediatric pneumonia what age groups?
Wh
at age groups are more likely to develop pneumonia?
- -Highest in infancy
- -Relatively high in childhood
They have a
- greater risk of contracting the disease
- their immune system is not fully developed.
What are the etiological agents of paediatric pneumonia?
- Most are caused by viruses or bacteria
- Approximately 1/3rd of paediatric pneumonias are due to a combination of viral and bacterial infections (mixed infection)
- Age is a very important factor in the ethology
- Viruses are more common in younger children, while bacteria become commoner in older children
- But in about 50% no pathogen is identified
Neonate
- organisms acquired from the maternal genital tract e.g. GBS, E coli, Klebsiella and Listeria monocytogenus
- Most common virus - RSV
Infants and young children
- Respiratory viruses – RSV, Influenza and Parainfluenza, Adeno, Entero and Corona viruses
- Bacteria – Streptococcus Pneumoniae, Staphylococcus aureus (rare, but serious), non-typable Haemophilus influenzae [contribution by Hib depends on immunisation status]
Children > 5 years
- Mycoplasma pneumoniae
- Streptococcus pneumoniae
- Chlamydia pneumoniae
- Myco and Clamy different antibiotics than strep
- Consider Mycobacterium tuberculosis at all ages.
PCV 13 >>> coz commonest strain
Recurrent pneumonia should raise the suspicion of an underlying disorder such as immunodeficiency, anatomical abnormalities or congenital heart disease.
There is no single definition for pneumonia. It is defined in terms of symptoms, signs and clinical course. WHO defines pneumonia as a febrile illness with tachypnoea for which there is no other apparent cause.
There are two further clinical definitions for pneumonia. Bronchopneumonia is a febrile illness, with cough, respiratory distress with evidence of localized or generalized patchy infiltrates on chest x - tray. Lobar pneumonia is similar to bronchopneumonia except that the physical findings and radiographs indicate lobar consolidation
Clinical presentation of CAP
The illness may start with symptoms of upper respiratory tract infection followed by the signs of lower respiratory tract infection. Tachypnoea, intercostal and subcostal recessions, restlessness and drowsiness may indicate the severity of pneumonia. Tachypnoea with chest indrawing is the best predictor of pneumonia of children in all age groups.
- Clinical presentation varies with age
- The younger the child symptoms are non-specific
- Cough and fever which are hallmarks of pneumonia in adults may be absent in younger children
NEONATES
Symptoms and signs - Non-specific
Poor feeding
Irritability
Abdominal distension
Lethargy
Respiratory distress - high RR, chest in-drawing, grunting etc.
YOUNGER INFANTS ( AFTER NEONATAL PERIOD)
- “Unwell” child
- Fever
- Poor feeding
- Cough
- Tachuypnoea and chest recessions- noticed by parents - used as a feature to diagnose CAP
OLDER CHILDREN
- “Unwell” child - poor feeding, lethargy
- Fever
- Cough!
- Tachypnoea
- Difficulty in breathing
- Constitutional symptoms - headache, vomiting, diarrhoea
- Chest, abdominal or neck pain - pleuritic pain
PHYSICAL SIGNS
- May be difficult to appreciate in neonates and very young children
- Tachypnoea is the most easily appreciated sign
Fever
Nasal flaring
Recessions - intercostal, subcostal, supracostal, substernal
Grunting - especially in neonates and smaller infants
May hear coarse end inspiratory crepitations over the affected areas (might be due to conductedsounds from secretions in upper airways so cough and change position)
Classic signs of consolidation - reduced air entry, increased vocal fremits and bronchial breathing may be difficult to demonstrate in smaller infants.
Bacterial LRTI vs Viral LRTI
Diagnosis of CAP
Diagnosis is by usually by a combination of clinical, radiological, haematological and microbiology features.
Clinical
- Respiratory rate
- Respiratory effort - chest recessions / working of accessory muscles of respiration
- Oxygen saturation
- Presence of cyanosis
Radioloigical
- Chest xray (consolidation, pleural effusion) - poor indicators of aetiology and severity - do not perform routinely in mild uncomplicated acute LRTI
- Ultrasonography - this has been shown to accurately diagnose pneumonia in infants and children. May eventually replace xrays.
- CT / MRI if indicated
Haematological
- FBC (hint at bacterial neutrophilic leucocytosis vs viral)
- CRP (do not distinguish between bacterial and viral infections in children and should not be measured routinely)
Microbiological
- PCR of nasopharyngeal aspirate
- Cultures (colonised organisms!) - sputum / blood (younger infants) / nasopharyngeal aspirate / pleural fluid / bronchial aspirate (When facilities are available blood cultures should be performed in children suspected of having bacterial pneumonia [B]. Acute serum samples for antibodies may be saved and a convalescent sample taken in cases where a microbiological diagnosis was not reached during the acute illness [B]. When significant pleural fluid is present, it could be aspirated for diagnostic purposes and sent for microscopic examination and culture. Another specimen could be saved for bacterial antigen detection [B].)
- Serology (esp for mycoplasma) - acute and convalescent
...
Follow up chest radiography should only be performed after lobar collapse, an apparent rounded opacity, or for continuing symptoms
MANAGEMENT OF CAP
Most
CAP can be managed at home!!!
Indications
for admissiongraftedd
- SaO2 < 93%
- Severe tachypnoea
- Difficulty in breathing
- Grunting
- Apnoea
- Not feeding
- Family unable to provide appropriate care (relative)
INITIAL PRIORITIES
Priorities
in children with pneumonia admitted to hospital
- Respiratory support for those having grunting, flaring, severe tachypnea, and retractions - HIgh flow oxygen via face mask /Nasal canulae (Oxygen should be administered to children who are restless, tachypnoeic with severe chest indrawing (Oxygen saturation < 92%))
- Those unable to maintain oxygenation by above means or develop decreasing level of consciousness and hypercapnia may need PPV /CPAP
OTHER SUPPORTIVE CARE
- General supportive care
- Analgesic for pain, headache etc.
- Antipyretics
- IV fluids if not drinking adequately (When a child is in severe respiratory distress oral intake may be impaired. Intravenous fluid can be administered, but should be done cautiously, since syndrome of inappropriate ADH secretion is a possibilit)
- Attention to nutrition - NG feeds if needed
In the ill child minimal handling may reduce metabolic and
oxygen requirement.
There is no proven benefit of giving anti-tussives in pneumonia.
Routine chest physiotherapy is not recommended [B].
Follow up chest radiography should be performed after lobar collapse, an
apparent rounded opacification, or for continuing symptoms
ANTIBIOTIC THERAPY
If the clinical diagnosis is bronchopneumonia or lobar pneumonia empirical
treatment is necessary to reduce the morbidity and mortality since the possible
organisms are difficult to predict.
Intravenous antibiotics should be used in pneumonia when the child has signs
of severe pneumonia and vomiting which disturbs oral intake
Determined
by the most likely causative organism
Which
is indicated by
- where the disease was acquired - Community vs hospital
- age
- severity of illness
- appearance of chest x ray
Neonates
- Broad spectrum IV antibiotics to cover both gram positive and negative organisms
- Combination therapy (ampicillin and either gentamicin or cefotaxime) is typically used in the initial treatment of newborns and young infants
Older
infants and children
High
dose oral amoxycillin is the first line
antibiotic for children with uncomplicated CAP (Co-amoxyclav
acceptable)
- Second- or third-generation cephalosporins and macrolide antibiotics such as azithromycin (older children - myco and clamy!) are acceptable alternatives.
- For staphylococcal and resistant pneumococcal infections Vancomycin may be needed
Children
who are toxic appearing should receive antibiotic therapy that includes
vancomycin (particularly in areas where penicillin-resistant pneumococci and
methicillin-resistant S aureus [MRSA] are prevalent) along with a
second- or third-generation cephalosporin.
Complications of CAP
- Pulmonary
- Metastatic
- Systemic
Pulmonary complications
- Pleural effusion
- Empyema
- Lung abscess
- Pneumothorax
- Broncho-pleural fistula
- Necrotizsng pneumonia
- Acute respiratory failure
Metastatic Complications (neonates or children with undelying immune deficiencies!)
- Meningitis
- Cerebral abscess
- Pericarditis
- Endocarditis
- Osteomyelitis
- Septic arthritis
Systemic complications
- Systemic inflammatory response syndrome or sepsis
- Haemolytic ureamic syndrome
Management of pulmonary complications
- Pleural effusions - usually these are sympathetic effusions and resolve with appropriate antibiotic therapy
- Empyema and lung abscess
- -May require drainage with a chest drain
- -Installation of a fibrinolytic agent in the intrapleural space (e.g. urokinase)
- -Surgical decortication may be needed
Prognosis
- Overall, the prognosis is good.
- Most cases of viral pneumonia resolve without treatment
- Common bacterial pathogens and atypical organisms respond to antimicrobial therapy
- Staphylococcal pneumonia although rare, can be very serious despite treatment
- Long-term alteration of pulmonary function is rare, even in children with pneumonia that has been complicated by empyema or lung abscess.
Prevention
- Counsel parents
- -prevent exposure of infants to tobacco smoke
- -Importance of hand washing / (? face covering) regarding later infectious exposures in daycare centers, schools, and similar settings
- - benefit of pneumococcal immunization and annual influenza immunizatin
CAP X-Rays
- lobar pneumonia (most likely strep pneu)
- developin into a bronchoneumona maybe viral developing into bacterial? more severe
- right mid zone consolidation (not that symptomatic!)
- consolidation right upper lobe (lower border convex downwards - very small children -classical klebsiella - high power anti)
pneumotoceles - hallmarks of staph pneu can rupture and form penumothorax
bronchopenu or miliary TB!!!
Atypical pneumonia
Definition
Atypical pneumonia refers to pneumonia caused by the following organisms
- Mycoplasma pneumoniae
- Chlamydia pneumoniae
- Legionella pneumophila
Atypical pneumonia due to Mycoplasma often causes milder form of pneumonia. They are characterized by a protracted course of illness unlike other forms of pneumonia that can present acutely with more severe early symptoms. However pneumonia due to Legionella could be severe.
Symptoms
Mycoplasma Pneumonia
Mycoplasma pneumoniae is a common cause of community acquired pneumonia in the older child [11]. The commonest age group affected is 5- 15 yrs. It is rare under 4 years. The younger child attending daycare is at risk3
Cinical Presentation
Ix - FBC is not helpful
Radio -Â There is no radiological feature that is pathagnomonic of mycoplasma pneumonia. Interstitial infiltrates, lobar consolidation, hilar adenopathy have all been described. Pleural effusions are rare
Serological testing
Treatment
Macrolides are used if Mycoplasma or Chlamydia pneumoniae are suspected [D]. Because mycoplasma pneumonia is more prevalent in older children macrolide antibiotics may be used as first line empirical treatment in children aged 5 and above with community acquired pneumonia. [D]
Erythromicin 40mg/kg/ day orally 6 hourly for 7-10 days
Azithromicin 12mg/kg as a single daily dose for 5 days
Clarithromicin 15 mg/kg day 12 hourly for 10 days.
The newer macrolides are better tolerated and have lesser dosing frequency. Antibiotic prophylaxis for household contacts is not routinely recommended. However, if there are high risk household contacts, consider prophylaxis.
Clamydia Penumonia
Chlamydia pneumoniae causes atypical community acquired pneumonia indistinguishable clinically from mycoplasma pneumonia14.Both can co-exist in CAP in children.
DIagnosis -Â Chest x ray shows bilateral chest expansion with diffuse infiltrates. 15 Serological testing can distinguish it from the other chlamydial illnesses. (eg. psitacossis, trachoma)
Treatment -Â Macrolides are recommended as above
Legionella Pneumonia
Number of reported cases of legionella in childhood is small. Both community acquired and nosocomial cases of Legionellosis are seen in children. Most children with Legionaire disease are immunosuppressed.
Three epidemiological patterns are recognized.
1. Outbreaks in previously fit individuals staying in hotels, institutions or hospitals where the cooling systems or shower facilities are contaminated with the organism.
2. Sporadic cases are seen in children.
3. Outbreaks occur in immunocompromised patients.
A strong presumptive diagnosis of legionella pneumonia can be made if following clinical features are present.
• A prodromal illness like a viral infection
- A dry cough,confusion or diarrhoea
- Lymphopenia without marked leukocytosis
- Hyponatraemia
Diagnosis
Four fold rise in antibody titre
Urinary antigen test – highly specific
Treatment
Macrolides are the drugs of choice
Nosocomial Penumonia (Hospital Acquired penumonia)
Nosocomial pneumonia is pulmonary infiltrates occurring in a patient who has been hospitalized for 1 week or more which is compatible in appearance with a bacterial pneumonia. Within 1 week of hospitalization, the normal respiratory flora of the patient is displaced by the nosocomial organisms. (Aerobic gram negative bacilli or Staphylococcus aureus)
Risk factors
- Aspiration
- Intubation
- Bacteraemia
Microbiology of nosocomial pneumonia
Common causes
- Pseudomonas aeruginoa
- Klebsiella pneumoniae
- E.coli
Uncommon pathogens
- Serratia
• Acinobacter
Legionella
Staphylococcus aureus is a rare cause of infection though it colonizes respiratory tract commonly. However in neonatal intensive care units (NICU) methicillin resistant Staphylococcus aureus (MRSA) is a common pathogen. Paediatric intensive care units have higher incidence of Pseudomonas aeriginosa infection compared to neonatal intensive care units. Klebsiella and E. coli are more prevalent in paeditric than in adult intensive care units. Anaerobes and multiple organisms are often found in aspiration pneumonia
Presentation of nosocomial pneumonia
Necrotizing pneumonia with rapid cavitation within 72 hours is the hallmark of pseudomonas and staphylococcal pneumonias. The cavitation in klebsiella pneumonia occurs 3-5 days after the onset of nosocomial infection.
Treatment of nosocomial pneumonia
Monotherapy is now the preferred choice with broad spectrum drugs that cover klebsiella pneumoniae and pseudomonas. Following table of drugs can be used in the treatment of nosocomial infection considering sensitivity patterns of the isolated micro-organisms
POORLY RESOLVINGÂ PNEUMONIA
Definition
Less than 50% clearing of radiological abnormalities at 2 weeks and less than complete clearing of abnormalities by 4 weeks.
Factors contributing to a poor clinical response to empirical antimicrobial therapy in patients with acute pneumonia
a) Drug factors
1. Inappropriate antimicrobial agents
2. Inappropriate dosing regimes
3. Drug Hypersensivity or other adverse effects
b) Host factors
1. Poor host defences Immune deficiency Malnutrition Endobronchial obstruction Significant co-morbidity –diabetes, malignancy, gastroesophgeal reflux.
2. Age of the child
3. Phlebitis –cannula infection, ceep cein chrombosis
c)Complication of pneumonia
1. Infective complications Empyema or abscess Metastatic spread – septic arthritis, endocarditis, pneumonia Superinfections
2. Noninfective complications – hypoxia, dehydration
3. Effusions
4. Atelectasis
d) Incorrect Diagnosis
Incorrect microbiological diagnosis
1. Mycobacterial infections
2. Atypical pneumonias
3. Opportunistic organisms
Incorrect pathological diagnosis
1. Endobronchial obstruction
2. Bronchiectasis
3. Cystic fibrosis
4. Pulmonory sequestration
PENUMONIA IN THE IMMUNOCOMPROMISED CHILD
Â
Case book
Â
Casebook
Â
Â
Â
Â
Â
Â
Guidelines
Â
Â